Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Sales | 5 | 10 | 15 | 17 | 8 |
Gross Profit | 5 | 10 | 15 | 17 | 8 |
Operating Expenses | 3,985 | 4,179 | 4,295 | 4,861 | 6,279 |
Operating Income | -3,980 | -4,169 | -4,280 | -4,844 | -6,271 |
Pre-tax Income | -3,980 | -4,169 | -4,280 | -4,844 | -6,271 |
Net Income Continuous | -3,980 | -4,169 | -4,280 | -4,844 | -6,271 |
Net Income | $-3,980 | $-4,169 | $-4,280 | $-4,844 | $-6,271 |
EPS Basic Total Ops | -0.15 | -0.17 | -0.18 | -0.20 | -0.26 |
EPS Basic Continuous Ops | -0.16 | -0.17 | -0.18 | -0.20 | -0.26 |
EPS Diluted Total Ops | -0.15 | -0.17 | -0.18 | -0.20 | -0.26 |
EPS Diluted Continuous Ops | -0.16 | -0.17 | -0.18 | -0.20 | -0.26 |
EBITDA(a) | $-3,979 | $-4,168 | $-4,279 | $-4,842 | $-6,268 |